Decoding calcium signals involved in cardiac growth and function

Nature Medicine

Volumn 6, Issue 11, 2000, Pages 1221-1227

  Frey, N ^a   McKinsey, T A ^a   Olson, E N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALMODULIN; FK 506 BINDING PROTEIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

CALCIUM CELL LEVEL; CELL GROWTH; ENZYME ACTIVATION; HEART DEVELOPMENT; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOMERE; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM SIGNALING; CALMODULIN; CARDIOMEGALY; GENE EXPRESSION REGULATION; HEART; HUMANS; MYOCARDIAL CONTRACTION;

EID: 0033678548     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/81321     Document Type: Review

References (79)

1. Beta-adrenergic receptors and receptor signaling in heart failure
2. 'Stress-responsive' mitogen-activated protein kinases (c-jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
3. 2+ sparks
4. Phospholamban: A prominent regulator of cardiac contractility
5. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure
6. 2+-ATPase gene expression in the human ventricle during end-stage heart failure
7. +-exchanger protein levels and diastolic function of failing human myocardium
8. PKA phoshorylation dissociates FKBP12.6 from the calcium release channel (Ryanodine receptor): Defective regulation in failing hearts
9. Altered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathy
10. A mutant tropomyosin that causes hypertrophic cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity
11. 2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy
12. Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy
13. Altered regulatory function of two familial hypertrophic cardiomyopathy troponin T mutants
14. Role of troponin I proteolysis in the pathogenesis of stunned myocardium
15. Transgenic mouse model of stunned myocardium
16. Calmodulin: A prototypical calcium sensor
17. Calcium oscillations increase the efficiency and specificity of gene expression
18. Junctophilins: A novel family of junctional membrane complex proteins
19. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression
20. The multifunctional calcium/calmodulin-dependent protein kinase: From form to function
21. Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus
22. The CaM kinase II hypothesis for the storage of synaptic memory
23. 2+ response amplitude and duration
24. 2+ signals and immunosuppression
25. 2+-stimulated actomyosin MgATPase activity
26. Myosin light chain phosphorylation in vertebrate striated muscle: Regulation and function
27. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity
28. Reversible inhibition of the calcium-pumping ATPase in native cardiac sarcoplasmic reticulum by a calmodulin-binding peptide
29. 2+/calmodulin-dependent protein kinase
30. Sequence analysis of phospholamban: Identification of phosphorylation sites and two major structural domains
31. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels
32. 2+/calmodulin-dependent kinase is altered in heart failure
33. 2+/calmodulin-dependent protein kinase in failing and non-failing human hearts
34. 2+ flux
35. Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons
36. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes
37. Signaling pathways for cardiac hypertrophy and failure
38. Cardiac hypertrophy: Sorting out the circuitry
39. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice
40. Induction of natriuretic factor and myosin light chain- 2 gene expression in cultured ventricular myocytes by electrical stimulation
41. Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
42. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin
43. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
44. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
45. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
46. Increased calcium sensitivity of chemically skinned human atria by myosin light chain kinase
47. Abnormal cardiac structure and function in mice expressing non-phosphorylatable regulatory myosin light chain 2
48. Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro
49. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
50. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy
51. Transcription factors of the NFAT family: Regulation and function
52. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
53. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type
54. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons
55. 2+-dependent gene expression mediated by MEF2 transcription factors
56. Calcineurin signaling and muscle remodeling
57. Prevention of cardiac hypertrophy in mice by calcineurin inhibition
58. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
59. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
60. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
61. Pressure overload induces severe hypertrophy in mice treated with cyclosporin, an inhibitor of calcineurin
62. Calcineurin and human heart failure
63. Revisiting calcineurin and human heart failure
64. Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium
65. Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes
66. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
67. Chronic elevation of calmodulin in the ventricles of transgenic mice increases the autonomous activity of calmodulin-dependent protein kinase II, which regulates atrial natriuretic factor gene expression
68. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases
69. MEF-2 function is modified by a novel co-repressor, MITR
70. Roles of histone acetyltransferases and deacetylases in gene regulation
71. Regulation of skeletal muscle differentiation by signal-dependent nuclear export of a histone deacetylase
72. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4
73. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
74. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium
75. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
76. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling
77. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts
78. Low- and high-level transgenic expression of beta-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice
79. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice